Ariad Pharma (ARIA) Posts Wider than Expected Q2 Loss of 31c/Share
Tweet
Share
E-mailGet Alerts ARIA Hot Sheet
Price: $25.78 -0.96%
Financial Fact:
Total operating expenses: 71.01M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Total operating expenses: 71.01M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Ariad Pharma (NASDAQ: ARIA) reported Q2 EPS of ($0.31), $0.04 worse than the analyst estimate of ($0.27).
For earnings history and earnings-related data on Ariad Pharma (ARIA) click here.
For earnings history and earnings-related data on Ariad Pharma (ARIA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
